Trusted News Discovery Since 2008
{{/content}}
AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US
Video Credit: Wochit
Published on October 23, 2020 - Duration: 00:32s
AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US
AstraZeneca and the University of Oxford got the go-ahead to restart their US coronavirus vaccine trials.
The late-stage trial was stopped due to a possible adverse reaction in one of the participants.
On September 6 AstraZeneca reported a "suspected serious adverse reaction".
According to Business Insider, the reaction occurred in a UK-based participant.
The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September.
The trials in Japan resumed earlier this month.
You are here
Related news from verified sources
Brazilian newspaper O Globo reported that the volunteer had been given a placebo and not the trial vaccine, citing unnamed sources
on October 21, 2020 • Hindu
Worldwide coronavirus cases cross 41.04 million, death toll over 1.12 million.
on October 22, 2020 • Hindu
‘The FDA reviewed all safety data from trials globally and concluded it was safe to resume the trial’
on October 23, 2020 • Hindu
Related videos from verified sources
COVID-19 vaccine trial progressing with help from Valley participants 02:21
Video credit: ABC15 Arizona - Published on October 31, 2020
UCHealth Looking For Coloradans To Participate In COVID-19 Vaccination Trial 02:32
Video credit: CBS 4 Denver - Published on October 29, 2020
'You Cannot Get COVID From These Vaccines': Moderna COVID Vaccine Trial Works To Ensure Safety 01:57
Video credit: WBZ CBS Boston - Published on October 28, 2020